Stephen W. Webster - 09 Dec 2021 Form 4 Insider Report for TCR2 THERAPEUTICS INC.

Role
Director
Signature
/s/ Margaret Siegel as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Dec 2021
Net transactions value
$0
Form type
4
Filing time
10 Dec 2021, 15:36:15 UTC
Previous filing
25 Mar 2022
Next filing
23 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (Right to Buy) Award $0 +12,100 $0.000000 12,100 09 Dec 2021 Common Stock 12,100 $5.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.